Skip to main content
15 January 2025
Last updated:
Tuesday 14 January 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Due diligence is more than a numbers game
Read more
The role of technology providers in biotech
Read more
Making the most of EU funding
Read more
$2 billion in new US funding
Read more
BIO meeting gets boost from the Dendreon effect
Read more
Corporate venture capital shifts to a higher gear
Read more
Filling pipelines is an art rather than a science
Read more
Financial thermometer rises at JP Morgan meeting
Read more
Alternative funding strategies for biotech
Read more
AXA Framlington looks for a bottom in biotech
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Page
4
Page
5
Current page
6
Page
7
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form